Defining optimal immunotherapies for type 1 diabetes. Introduction.
von Herrath
Matthias
M
La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
D001324:Autoantigens / Q000276:immunology*; D015551:Autoimmunity / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy
D001324:Autoantigens